The genetic tumor background is an important determinant for heterogeneous MYCN ‐amplified neuroblastoma-Reference-Cited by-同舟云学术

The genetic tumor background is an important determinant for heterogeneous MYCN ‐amplified neuroblastoma

Published:2016-03-22 Issue:1 Volume:139 Page:153-163
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bogen Dominik¹,Brunner Clemens¹,Walder Diana¹,Ziegler Andrea¹,Abbasi Reza¹,Ladenstein Ruth L.²³,Noguera Rosa⁴,Martinsson Tommy⁵,Amann Gabriele⁶,Schilling Freimut H.⁷,Ussowicz Marek⁸,Benesch Martin⁹,Ambros Peter F.¹³,Ambros Inge M.¹

Affiliation:

1. Department of Tumor BiologyCCRI, Children's Cancer Research InstituteSt. Anna KinderkrebsforschungVienna Austria

2. S²IRP, CCRI, Children's Cancer Research InstituteSt. Anna KinderkrebsforschungVienna Austria

3. Department of PediatricsMedical University of ViennaVienna Austria

4. Pathology DepartmentMedical School, University of Valencia, INCLIVAValencia Spain

5. Department of Clinical GeneticsInstitute of Biomedicine, Sahlgrenska Academy, University of GothenburgGothenburg Sweden

6. Department of Clinical PathologyMedical University of ViennaVienna Austria

7. Pediatric OncologyOlgahospital, Klinikum StuttgartStuttgart Germany

8. Department of Pediatric Oncology, Hematology and BMTWroclaw Medical UniversityWroclaw Poland

9. Division of Pediatric Hematology/OncologyDepartment of Pediatrics and Adolescent MedicineMedical University of GrazGraz Austria

Funder

Austrian Science Fund

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30050

Reference42 articles.

1. The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

2. Neuroblastoma

3. Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage

4. Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas

5. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroblastoma Interaction with the Tumour Microenvironment and Its Implications for Treatment and Disease Progression;Current Oncology;2023-10-15

2. Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance;Journal of Dr Behcet Uz Children s Hospital;2023-08-09

3. Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance;J DR BEHCET UZ CHILD;2023

4. Neural crest cells development and neuroblastoma progression: Role of Wnt signaling;Journal of Cellular Physiology;2022-12-11

5. Neuroblastoma-associated chromosomal aberrations drive cell identity loss in human neural crest via disruption of developmental regulators;2022-11-23